FIELD: chemistry.
SUBSTANCE: invention refers to new compounds of general formula (I): 
where: R1 stands for either hydrogen atom, or direct or branched (C1-C7)alkyl; R2 stands for either direct or branched (C1-C7)alkyl, or (C3-C7)cycloalkyl, or (C3-C7)cycloalkyl(C1-C3)alkyl; X stands for hydrogen atom or halogen; R3 stands for either hydrogen atom, or one or more sibstitutes chosen from halogen atoms and following groups: trifluoromethyl, direct or branched (C1-C6)alkyl, (C1-C6)alkoxyl, or group of general formula NR4R5 where R4 and R5 stand for hydrogen atom; as free base or additive salt with acid. Additionally, the invention concerns medical product, pharmaceutical composition, and application.
EFFECT: production of new biologically active compounds active to specific inhibitors of glycine glyt 1 and/or glyt 2 carriers.
10 cl, 4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| N-[HETEROARYL(PIPERIDINE-2-YL)METHYL]BENZAMIDE DERIVATIVES AND APPLICATION IN THERAPY | 2004 |
|
RU2351596C2 |
| N-PHENYL(PIPERIDINE-2-YL)METHYL-BENZAMIDE DERIVATIVES, AND THEIR APPLICATION IN THERAPY | 2004 |
|
RU2351588C2 |
| DERIVATIVES OF N-[PHENYL(PYRROLIDIN-2-YL)METHYL]BENZAMIDE AND N-[(AZEPAN-2-YL)PHENYLMETHYL]BENZAMIDE, METHOD OF OBTAINING SAID COMPOUNDS AND USE THEREOF IN THERAPY | 2004 |
|
RU2386614C2 |
| DERIVATIVES OF N-HETEROCYCLYLMETHYLMENZAMIDES, OBTAINMENT AND APPLICATION IN THERAPY | 2004 |
|
RU2346945C2 |
| TETRAHYDROPYRANE DERIVATIVES FOR NEUROLOGICAL DISEASES | 2011 |
|
RU2554344C2 |
| AROYLAMINO- AND HETEROAROYLAMINO-SUBSTITUTED PIPERIDINES AS GLYT-1 INHIBITORS | 2010 |
|
RU2517701C2 |
| PIPERIDINBENZOLSULFAMIDE DERIVATIVES | 2004 |
|
RU2330842C2 |
| SUBSTITUTED PHENYL METHANONE DERIVATIVES | 2007 |
|
RU2437872C2 |
| DIAZASPIROPIPERIDINE DERIVATIVES | 2004 |
|
RU2355690C2 |
| SUBSTITUTED BENZAMIDE DERIVATIVES | 2010 |
|
RU2595902C2 |
